FDA proposes to exclude semaglutide, tirzepatide from compounding list

Go back to FDA proposes to exclude semaglutide, tirzepatide from compounding list
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1210.02 --0 (-0%)
Previous Close $1210.02    52 Week High $88.16 
Open $1210.02    52 Week Low $67.88 
Day High $1210.02    P/E 280.10 
Day Low $1210.02    EPS $4.32 
Volume 5,309       

NOVO-NORDISK A/S (NYSE: NVO) Delayed: 51.58 --0 (-0%)
Previous Close $51.58    52 Week High $59.00 
Open $51.58    52 Week Low $32.80 
Day High $51.58    P/E N/A 
Day Low $51.58    EPS $0.00 
Volume 96,263